Cimetidine in gastro-oesophageal reflux

Area of Science:

• Gastroenterology and clinical pharmacology.

Background:

• Acid gastro-oesophageal reflux disease (GERD) is a common condition characterized by stomach acid flowing back into the esophagus.
• Effective management of GERD symptoms and objective reduction of reflux episodes are crucial for patient well-being.

Purpose of the Study:

• To evaluate the efficacy of cimetidine in treating acid gastro-oesophageal reflux.
• To compare the effects of different daily doses of cimetidine (1g or 2g) against a placebo.

Main Methods:

• A 15-hour intra-oesophageal pH monitoring was conducted.
• Symptom scores were collected and analyzed.
• Patients received either cimetidine (1g or 2g daily) or a placebo.

Main Results:

• Cimetidine significantly reduced the number of reflux episodes as measured by intra-oesophageal pH monitoring.
• Significant reductions in night pain and antacid consumption were observed in the cimetidine groups.
• Other GERD symptoms did not show significant differences between groups.
• Symptomatic improvement appeared greater in smokers than in non-smokers.

Conclusions:

• Cimetidine demonstrates efficacy in reducing both objective measures of reflux and key subjective symptoms in patients with acid GERD.
• The findings suggest a potential differential response to cimetidine based on smoking status.
• Further research may explore the mechanisms behind this observed difference.